Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy

被引:1
作者
Wang, Weiwei [1 ]
Qu, Chaoyi [1 ]
Yan, Huanhuan [1 ]
机构
[1] Xian Peoples Hosp, Shaanxi Eye Hosp, Xian Hosp 4, Xian, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
proliferative diabetic retinopathy; vitrectomy; conbercept; intravitreal; network meta-analysis; PARS-PLANA VITRECTOMY; LINEAR MIXED MODELS; SYSTEMATIC REVIEWS; HEALTH-CARE; INCONSISTENCY; BEVACIZUMAB; PRETREATMENT; RANIBIZUMAB;
D O I
10.3389/fendo.2023.1098165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeIntravitreal Conbercept (IVC) has been shown to be effective in treating proliferative diabetic retinopathy (PDR) as an adjuvant in pars plana vitrectomy (PPV); however, the best timing of IVC injection remains unknown. This network meta-analysis (NMA) sought to ascertain the comparative efficacy of different timings of IVC injection as an adjuvant to PPV on PDR. MethodsA comprehensive literature search was conducted in PubMed, EMBASE, and the Cochrane Library to identify relevant studies published before August 11, 2022. According to the mean time of IVC injection before PPV, the strategy was defined as very long interval if it was > 7 days but <= 9 days, long interval if it was > 5 days but <= 7 days, mid interval if it was > 3 days but <= 5 days, and short interval if it was <= 3 days, respectively. The strategy was defined as perioperative IVC if IVC was injected both before and at the end of PPV, and the strategy was intraoperative IVC if injected immediately at the end of PPV. The mean difference (MD) and odds ratio (OR) with corresponding 95% confidence interval (CI) for continuous and binary variables, respectively, were computed through network meta-analysis using Stata 14.0 MP. ResultsEighteen studies involving 1149 patients were included. There was no statistical difference between intraoperative IVC and control in treating PDR. Except for a very long interval, preoperative IVC significantly shortened operation time, and reduced intraoperative bleeding and iatrogenic retinal breaks. Long and short intervals reduced endodiathermy application, and mid and short intervals reduced postoperative vitreous hemorrhage. Moreover, long and mid intervals improved BCVA and central macular thickness. However, very long interval was associated with an increased risk of postoperative vitreous hemorrhage (RR: 3.27, 95%CI: 1.84 to 5.83). Moreover, mid interval was better than intraoperative IVC in shortening operation time (MD: -19.74, 95%CI: -33.31 to -6.17). ConclusionsThere are no discernible effects of intraoperative IVC on PDR, but preoperative IVC, except for very long interval, is an effective adjuvant to PPV for treating PDR.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Clinical efficacy and acceptability of panretinal photocoagulation combined with conbercept for patients with proliferative diabetic retinopathy A protocol for systematic review and meta-analysis
    Wang, Liangyu
    Chen, Zhaoli
    Wang, Xiaoxue
    MEDICINE, 2021, 100 (17) : E25611
  • [42] Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study
    Irini Chatziralli
    Eleni Dimitriou
    George Theodossiadis
    Evgenia Bourouki
    Eleni Bagli
    George Kitsos
    Panagiotis Theodossiadis
    International Ophthalmology, 2020, 40 : 841 - 847
  • [43] Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study
    Chatziralli, Irini
    Dimitriou, Eleni
    Theodossiadis, George
    Bourouki, Evgenia
    Bagli, Eleni
    Kitsos, George
    Theodossiadis, Panagiotis
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (04) : 841 - 847
  • [44] Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage
    Xu, Yao
    Ye, Qing
    Shen, Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (06) : 1066 - 1072
  • [45] Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy
    Huang, Zijing
    Chen, Li Jia
    Huang, Dingguo
    Yi, Jingsheng
    Chen, Zhiying
    Lin, Peimin
    Wang, Yifan
    Zheng, Jianlong
    Chen, Weiqi
    JOURNAL OF DIABETES RESEARCH, 2024, 2024
  • [46] PREDICTING VISUAL OUTCOMES OF SECOND EYE VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY
    Sulak, Marko
    Urbancic, Mojca
    Petrovic, Mojca Globocnik
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (04): : 698 - 707
  • [47] Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection
    Zhang, Xiao
    Wu, Jie
    Wu, Chan
    Bian, Ai-ling
    Geng, Shuang
    Dai, Rong-ping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [48] Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
    Xie, Xiao
    Lian, Chao
    Zhang, Zhiping
    Feng, Meng
    Wang, Wenqi
    Yuan, Xiaomeng
    Shi, Yanmei
    Liu, Tingting
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [49] Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
    Demir, Mehmet
    Oba, Ersin
    Can, Efe
    Kara, Orhan
    Cinar, Sonmez
    OPHTHALMOLOGY AND EYE DISEASES, 2013, 5 : 11 - 15
  • [50] Vitrectomy for proliferative diabetic retinopathy with asteroid hyalosis
    Ikeda, T
    Sawa, H
    Koizumi, K
    Yasuhara, T
    Kinoshita, S
    Tano, Y
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1998, 18 (05): : 410 - 414